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Fangjian Guo, MD,* Di He, BS,† Wei Zhang, MD,* R. Grace Walton, PHD‡
Birmingham, Alabama; Salt Lake City, Utah; and Lexington, Kentucky
Objectives The purpose of this study was to quantify the trends in blood pressure (BP), and the prevalence, awareness,
management, and control of hypertension in U.S. adults (20 years of age) from 1999 to 2010, and to assess
the efficacy of current clinical measures in diagnosing and adequately treating hypertensive patients.
Background Hypertension is a major independent risk factor for cardiovascular disease and stroke. Recent data indicate a
decreasing trend in hypertension prevalence, along with improvements in hypertension awareness, manage-
ment, and control.
Methods The study used regression models to assess the trends in hypertension prevalence, awareness, management,
and control from 1999 to 2010 among 28,995 male and female adults with BP measurements from a nation-
ally representative sample of the noninstitutionalized U.S. population (National Health and Nutrition Examination
Survey [NHANES] 1999 to 2010), with special attention given to 5,764 participants in NHANES 2009 to 2010.
Results In 2009 to 2010, the prevalence of hypertension was 30.5% among men and 28.5% among women. The hyper-
tension awareness rate was 69.7% (95% confidence interval [CI]: 62.0% to 77.4%) among men and 80.7% (95%
CI: 74.5% to 86.8%) among women. The hypertension control rate was 40.3% (95% CI: 33.7% to 46.9%) for
men and 56.3% (95% CI: 49.2% to 63.3%) for women. From 1999 to 2010, the prevalence of hypertension re-
mained stable. Although hypertension awareness, management, and control improved, the overall rates re-
mained poor (74.0% for awareness, 71.6% for management, 46.5% for control, and 64.4% for control in man-
agement); worse still, no improvement was shown from 2007 to 2010.
Conclusions From 1999 to 2010, prevalence of hypertension remained stable. Hypertension awareness, management, and
control were improved, but remained poor; nevertheless, there has been no improvement since 2007.
(J Am Coll Cardiol 2012;60:599–606) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.04.026Hypertension has been well recognized as a major indepen-
dent risk factor for cardiovascular disease and stroke (1).
Furthermore, hypertension has had great impact on health
outcomes and disparities (2–5). The National Health and
Nutrition Examination Survey (NHANES) provided blood
pressure (BP) data to track trends in the prevalence of
hypertension in U.S. adults (6,7). However, differences in
BP measurement techniques made it impossible to precisely
quantify trends in BP and hypertension prevalence in early
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accepted April 10, 2012.NHANES cycles (NHANES I, II) (7). The continuous
NHANES (from 1999 to 2010) standardized procedures for
BP measurement (8), providing an opportunity for precise
quantification of trends in the distribution of BP and
prevalence of hypertension. Data from early national surveys
revealed a decreasing trend in mean systolic blood pressure
(SBP) and hypertension prevalence from 1960 to 1980, and
from NHANES I (1971 to 1974) to NHANES III Phase 1
(1988 to 1991). Age-adjusted hypertension prevalence de-
creased by 15.9% from 36.3% to 20.4%, and hypertension
awareness, treatment, and control showed an increasing
trend during that period (7). However, hypertension prev-
alence increased from NHANES III (1988 to 1994) to
NHANES 1999 to 2000, with no improvement of aware-
ness, management, and control of hypertension (9). Be-
tween 1999 to 2000 and 2007 to 2008, prevalent hyperten-
sion remained constant (10). In this study, we assessed
whether current clinical approaches have been effective in
diagnosing and adequately treating hypertensive patients.
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Trends in Hypertension August 14, 2012:599–606We reported the trends in BP,
and prevalence, awareness, man-
agement, and control of hyper-
tension in the U.S. adult popula-
tion based on NHANES data
from 1999 to 2010.
Methods
NHANES. The NHANES is a
cross-sectional nationally repre-
sentative health and nutrition ex-
amination survey conducted by
the National Center for Health Statistics. The study was
approved by the National Center for Health Statistics
Institutional Ethics Review Board, and all adult participants
provided written informed consent (11). NHANES main-
tains high standards to ensure minimal nonsampling and
measurement errors during survey planning, data collection,
and processing (11). The survey uses a complex, stratified,
multistage probability sample to represent the civilian non-
institutionalized U.S. population. The NHANES sampling
procedure consists of 4 stages: counties, segments, house-
holds, and individuals (12). The participant response rate
ranged from 72.9% to 78.3% for interviews, and 68.6% to
72.7% for examinations at mobile examination centers
(MECs) among adults (20 years of age) for each survey
cycle through 1999 to 2010. In this report, only adult (20
years of age) participants with complete BP measurements
were included for analysis. We assessed progress in hyper-
tension prevention, diagnosis, and treatment using regres-
sion models with a 2-year survey cycle treated as a contin-
uous variable.
Definitions. BP was measured by mercury sphygmoma-
ometer using a standardized protocol (8). Mean SBP and
mean diastolic blood pressure (DBP) were calculated by
averaging 3 to 4 BP measurements. Hypertension was
defined as SBP 140 mm Hg or DBP 90 mm Hg, or on
ntihypertensive medication; pre-hypertension was deter-
ined as SBP120 mm Hg or DBP80 mm Hg, but not
eeting the criteria for hypertension (13).
Hypertension awareness, management, and control were
nalyzed in hypertensive participants based on question-
aires and BP measurements. Awareness was defined as
aving been informed of hypertension diagnosis; manage-
ent was defined as taking antihypertensive medication or
dopting lifestyle modifications (increasing activity or con-
rolling weight); hypertension control was defined as SBP
140 mm Hg and DBP 90 mm Hg, and was also
nalyzed in hypertensive participants who managed their
ypertension (control in management).
Body mass index (BMI) was calculated as weight in
ilograms divided by height in meters squared, and grouped
nto 3 categories: 25 kg/m2, 25 to 29.9 kg/m2 (over-
eight), and 30 kg/m2 (obesity). Race/ethnicity was
Abbreviations
and Acronyms
BMI  body mass index
BP  blood pressure
DBP  diastolic blood
pressure
NHANES  National Health
and Nutrition Examination
Survey
SBP  systolic blood
pressureelf-reported and was classified as non-Hispanic white, (on-Hispanic black, Mexican American, other Hispanic,
nd other. Age was categorized as 20 to 39, 40 to 59, and
0 years based on age at the interview. Education status
as classed into not completing high school, high school
nly, and higher education. Poverty income ratio was used
o reflect socioeconomic status, and 1 was determined to
e low income and1.85 was high income. Smoking status
as classed into nonsmoker (smoked 100 cigarettes life-
ime), past smoker, and current smoker.
tatistical analysis. Statistical analyses were carried out
ith SAS for Windows version 9.2 (SAS Institute, Cary,
orth Carolina). According to NHANES Analytic and Re-
orting Guidelines (11,14), all analyses took into account
ifferential probabilities of selection and the complex sample
esign, and nonresponse and noncoverage by using sample
eights and SAS survey analysis procedures. Standard
rrors were calculated using Taylor series linearization.
ge-adjusted values were adjusted to the standard popula-
ion (the 2000 Census population) by the direct method
sing the age groups 20 to 39, 40 to 59, and 60 years.
inear trends in the distributions of mean SBP and DBP,
nd prevalence, awareness, management, and control of
ypertension between 1999 and 2010 were assessed with
egression models with a 2-year survey cycle treated as a
ontinuous variable. Statistical significance was determined
s 2-sided p  0.05. To further examine trends in SBP and
BP, selected percentiles of SBP and DBP by sex in
HANES 1999 to 2010 were graphed.
esults
haracteristics. In NHANES 2009 to 2010, 6,218 adults
ere interviewed, 6,059 were examined at MECs, and
,764 with complete BP values were included for analysis.
rom 1999 to 2010, 32,464 adults were interviewed, 30,752
ere examined, and 28,995 were included for analysis. The
emographic characteristics of adult participants are shown
n Table 1. The age-adjusted higher education rate was
8.4% in 2009 to 2010, and there was an overall increase
rom 1999 to 2010 (p  0.004 for trend). Low income
revalence was 15.0% in 1999 to 2000, and decreased to
0.6% in 2005 to 2006, and then increased to 14.6% in 2009
o 2010. Participants (78.8%) were covered by health
nsurance in 2009 to 2010, with a 3% decrease from 1999 to
010 (p  0.019 for trend). Obesity prevalence increased
rom 30.0% to 35.5% from 1999 to 2010 (p  0.001).
urrent smokers decreased from 23.8% to 20.5% from 1999
o 2010 (p  0.017 for trend), whereas past smokers
emained stable at around 24%.
ean SBP and mean DBP and trends. Mean SBP and
BP from 1999 to 2010 are shown in Table 2. Age-
djusted mean SBP and DBP were 120 (95% CI: 120 to
21) mm Hg and 70 (95% CI: 69 to 71) mm Hg,
espectively, in 2009 to 2010, with a 4 mm Hg decrease in
BP and 3 mm Hg decrease in DBP since 1999 to 2000
p  0.001 for both trends). There was a significant
us popu
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August 14, 2012:599–606 Trends in Hypertensiondecrease for both SBP and DBP among both men and
women from 1999 to 2010. Selected percentiles of mean
SBP and DBP are presented in Figure 1. High percentiles
(75th to 95th) of mean SBP 130 mm Hg showed a
notable decreasing trend, especially in women. In 1999 to
2010, age explained 21.7% of the variance in mean SBP (R2
 0.217; p 0.001). Sex, ethnicity, age group, body weight
status, education level, income level, smoking status, and
marital status were strongly associated with mean SBP.
Similar patterns were observed for mean DBP, except that
income level became nonsignificant.
Prevalence of hypertension and pre-hypertension and
trends. Prevalence of hypertension and pre-hypertension is
presented in Table 3. The age-adjusted hypertension prev-
alence and pre-hypertension  hypertension prevalence
were 29.5% (95% CI: 27.7% to 31.4%) and 52.6% (95% CI:
50.1% to 55.0%), respectively, in 2009 to 2010, with no
significant improvement since 1999 to 2000. The prevalence of
pre-hypertension  hypertension only showed a slight de-
crease in the 60 years group and women. No improvement in
hypertension prevalence or pre-hypertension  hypertension
prevalence was observed among other groups. Throughout
1999 to 2010, the 60 years group had an almost 9-fold
higher hypertension prevalence than the 20- to 39-year-old
group (about 60% vs 6%). Hypertension prevalence did not
differ by sex; however, women had a much lower prevalence of
pre-hypertension than men from 1999 to 2010. Ethnicity, age
group, body weight status, education level, health insurance
coverage, and income level were strongly associated with
hypertension prevalence. There was a higher prevalence for
non-Hispanic blacks, the overweight and obese, the elderly,
and those covered by health insurance; the prevalence was
Age-Adjusted Characteristics of U.S. Adults (>20 Years): NHANESTable 1 Age-Adjusted Characteristics of U.S. Adults (>20 Yea
1999–2000 2001–2002 2003–20
Education status
High school 24.5 (21.8–27.2) 19.3 (17.2–21.4) 18.4 (16.0–
High school 25.9 (22.2–29.7) 25.7 (23.9–27.4) 27.0 (24.9–
Higher education 49.6 (45.2–54.0) 55.1 (51.9–58.2) 54.6 (51.8–
Poverty income ratio
1.00 15.0 (12.2–17.7) 13.5 (11.8–15.3) 12.6 (10.2–
1.85 64.8 (58.6–71.0) 68.3 (65.5–71.1) 68.7 (65.1–
Smoking status
Nonsmoker 50.6 (47.6–53.6) 50.5 (47.0–54.1) 49.1 (47.3–
Past smoker 25.4 (23.3–27.6) 25.2 (22.7–27.8) 25.3 (23.8–
Current smoker 23.8 (21.3–26.3) 24.2 (22.0–26.4) 25.6 (23.3–
Health insurance 81.8 (79.2–84.5) 83.4 (81.3–85.5) 82.3 (80.7–
Currently married 58.5 (53.9–63.1) 58.7 (56.1–61.2) 57.5 (54.6–
BMI (kg/m2)
25 35.4 (32.3–38.5) 33.3 (32.0–34.6) 33.4 (31.1–
25 to 30 33.7 (31.4–36.0) 33.8 (31.9–35.8) 34.0 (31.8–
30 30.0 (26.9–33.1) 28.6 (26.4–30.8) 31.4 (29.0–
Values are % (95% confidence interval). *p value for linear trend, assessed with regression models
Age adjusted: use the 20 to 39, 40 to 59, and 60 years age groups to adjust to the 2000 Cens
NHANES  National Health and Nutrition Examination Survey.lower for those with higher education.Awareness, management, and control of hypertension
and trends. Hypertension awareness, management, and
control are presented in Table 4. The age-adjusted aware-
ness rate was 74.0% (95% CI: 68.6% to 79.4%) in 2009 to
2010, 69.7% (95% CI: 62.0% to 77.4%) among men, and
80.7% (95% CI: 74.5% to 86.8%) among women. From
1999 to 2010, Mexican Americans had lower awareness
compared with non-Hispanic blacks and non-Hispanic
whites; the 20- to 39-year-old group had the lowest aware-
ness across sex and ethnic groups. In 2009 to 2010, 71.6%
(95% CI: 65.7% to 77.5%) of participants managed their
hypertension, and the age-adjusted management rate was
65.5% (95% CI: 57.5% to 73.5%) for men and 81.0% (95%
CI: 74.2% to 87.9%) for women. Similar to awareness,
Mexican Americans and the 20- to 39-year-old group also
had lower management rates. The age-adjusted control rate
was 36.8% (95% CI: 34.4% to 39.1%) in 1999 to 2010 and
46.5% (95% CI: 41.1% to 51.9%) in 2009 to 2010. Mexican
Americans had the lowest control rate, and non-Hispanic
whites had the highest control rate. Older participants
tended to have better hypertension control than the younger
group, except that non-Hispanic white older women had a
lower control rate compared with their younger counter-
parts. In 1999 to 2010, 64.4% (95% CI: 59.9% to 68.9%) of
participants attained BP control when managing their
hypertension. Among participants who managed their hy-
pertension from 1999 to 2010, men had lower control rate
than women; Mexican Americans and non-Hispanic blacks
had lower control rates than non-Hispanic whites; and older
people had a lower control rate than middle-aged people.
In 1999 to 2010, sex, ethnicity, age group, body weight
status, smoking, and health insurance coverage were all
to 2010HANES 1999 to 2010
2005–2006 2007–2008 2009–2010 p Value*
17.6 (14.8–20.4) 20.3 (17.4–23.3) 18.8 (16.9–20.6) 0.004
25.0 (23.2–26.7) 25.2 (22.5–27.8) 22.9 (20.7–25.0) 0.100
57.4 (53.5–61.3) 54.5 (49.7–59.4) 58.4 (55.7–61.1) 0.006
10.6 (9.3–12.0) 14.3 (12.0–16.6) 14.6 (12.7–16.6) 0.721
73.0 (69.9–76.1) 68.0 (64.3–71.7) 66.8 (64.1–69.5) 0.362
51.2 (48.7–53.7) 52.9 (49.5–56.4) 55.4 (52.2–58.5) 0.012
25.0 (22.9–27.2) 24.0 (22.6–25.4) 24.1 (21.8–26.5) 0.288
23.8 (21.2–26.4) 23.0 (20.1–25.9) 20.5 (19.0–22.0) 0.017
81.0 (77.5–84.4) 80.4 (78.3–82.4) 78.8 (76.9–80.8) 0.019
58.0 (55.4–60.6) 56.3 (53.4–59.2) 55.3 (53.5–57.2) 0.076
33.0 (30.3–35.6) 31.8 (30.0–33.6) 31.1 (28.6–33.7) 0.030
32.8 (31.1–34.5) 33.8 (32.1–35.6) 32.8 (30.8–34.7) 0.382
33.4 (30.5–36.2) 33.4 (31.2–35.6) 35.5 (33.7–37.3) 0.001
-year survey cycle treated as a continuous variable, and adjusted for sex, ethnicity, and age group.
lation by the direct method.1999rs): N
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Trends in Hypertension August 14, 2012:599–606rate was lower in men, Mexican Americans, the younger
group, those with normal body weight, and no health insur-
ance, but higher in past smokers. The same pattern was
observed in hypertension management and control. Addition-
ally, marital status was also strongly associated with hyperten-
sion control, with currently married persons having better
control rates. Overall, awareness, management, and control of
hypertension were significantly increased from 1999 to 2010.
However, awareness, management, and control rates remained
poor in 2009 to 2010, with rates of 74.0% for awareness, 71.6%
for management, 46.5% for control, and 64.4% for control in
management. Compared with 2007 to 2008, hypertension
prevalence and pre-hypertension  hypertension prevalence
emained constant (p  0.36 for both) in 2009 to 2010, and
oth men and women showed no improvement. Hypertension
wareness, management, control, and control in management
lso showed no improvement (p 0.89, 0.21, 0.92, and 0.095,
espectively), which was evident among both men and women.
iscussion
rom 1999 to 2010, age-adjusted mean SBP decreased by
mm Hg (p 0.001 for trend), especially for women (5 mm Hg;
 0.001 for trend). Mean DBP displayed a similar
attern, with a significant decrease of 3 mm Hg (p  0.001
Age–Adjusted Mean SBP and DBP Among U.S. Adults (>20 Years)Table 2 Age–Adjusted Mean SBP and DBP Among U.S. Adults
1999–2000 2001–2002 2003–2004
Mean SBP
All 124 (123–125) 123 (123–124) 123 (122–124
20–39 yrs 115 (113–117) 114 (114–115) 114 (114–115
40–59 yrs 123 (122–124) 123 (122–125) 124 (122–125
60 yrs 141 (139–143) 140 (138–142) 137 (135–139
Male 125 (124–127) 124 (123–125) 124 (123–126
NH white 124 (123–126) 123 (122–125) 124 (122–125
NH black 129 (127–130) 130 (129–130) 128 (126–130
Mex Am 127 (125–128) 124 (122–126) 124 (122–126
Female 123 (121–124) 123 (122–123) 122 (121–123
NH white 121 (120–123) 122 (121–123) 121 (120–122
NH black 128 (126–130) 128 (126–130) 127 (125–130
Mex Am 123 (122–125) 121 (121–122) 124 (122–126
Mean DBP
All 73 (72–74) 72 (71–73) 71 (71–72)
20–39 yrs 71 (70–72) 70 (69–71) 69 (68–70)
40–59 yrs 76 (76–77) 76 (75–77) 76 (75–77)
60 yrs 71 (69–72) 70 (69–71) 68 (67–69)
Male 75 (74–76) 74 (73–74) 72 (72–73)
NH white 75 (74–76) 74 (73–74) 72 (72–73)
NH black 76 (75–78) 76 (74–77) 74 (73–75)
Mex Am 75 (74–76) 72 (70–73) 71 (70–72)
Female 71 (70–72) 71 (70–72) 70 (69–71)
NH white 70 (69–71) 71 (69–72) 70 (69–71)
NH black 73 (72–74) 73 (72–74) 72 (70–73)
Mex Am 70 (69–71) 70 (69–71) 70 (69–71)
Values are mm Hg (95% confidence interval). *p value for linear trend, assessed with regression m
age group when appropriate. Age-adjusted: use the 20 to 39, 40 to 59, and 60 years age group
DBP  diastolic blood pressure; Mex Am  Mexican American; NH  non-Hispanic; SBP  sysor trend), and was significant for both men and women wp  0.001 for both). Prevalence of hypertension among
U.S. adults (20 years old) remained at a high level of
around 30%, whereas pre-hypertension prevalence decreased
in non-Hispanic black men (5.7%; p  0.023 for trend).
Awareness, management, and control of hypertension were
significantly improved in almost all sex/ethnic groups, but
remained poor, and did not improve from 2007 to 2010.
Therefore, effective prevention, detection, management, and
control of hypertension should continue to be important goals
for health policy, public health, and medical care decision
makers, as well as advocates and individuals at risk for hyper-
tension (15).
Trends in mean SBP and DBP. Our findings on trends in
mean SBP and mean DBP, and prevalence of hypertension
were consistent with other studies (10,15). From 1999 to
2010, mean SBP and mean DBP both decreased signifi-
cantly by 4 and 3 mm Hg, respectively (both trends, p 
.001). It was reported (10) from 1988 to 2008 that SBP
ecreased in individuals with hypertension, but increased
mong individuals without hypertension (p  0.02), which
ight have been caused by the adverse diet and lifestyle of
onhypertensive people. In our study, we found that mean
BP did not decrease among nonhypertensive participants
p  0.173 for all, p  0.268 for men, and p  0.274 for
NES 1999 to 2010Years): NHANES 1999 to 2010
2005–2006 2007–2008 2009–2010 p Value*
122 (121–123) 122 (121–122) 120 (120–121) 0.001
115 (114–116) 115 (114–115) 114 (114–115) 0.684
123 (122–124) 122 (121–123) 120 (119–122) 0.001
135 (133–137) 133 (132–135) 131 (130–132) 0.001
124 (123–125) 124 (123–124) 123 (122–123) 0.005
124 (122–125) 123 (122–124) 122 (122–123) 0.030
129 (128–130) 126 (124–128) 127 (124–129) 0.031
123 (122–125) 125 (122–128) 125 (124–126) 0.905
121 (120–122) 120 (119–120) 118 (117–119) 0.001
120 (119–121) 119 (118–120) 117 (116–118) 0.001
126 (124–127) 125 (123–126) 123 (121–126) 0.001
121 (118–123) 120 (117–122) 120 (119–121) 0.002
70 (70–71) 71 (70–72) 70 (69–71) 0.001
68 (67–69) 69 (68–70) 69 (67–70) 0.001
75 (74–76) 75 (74–76) 73 (72–75) 0.001
67 (66–68) 68 (68–69) 66 (65–67) 0.001
72 (71–72) 73 (72–73) 72 (70–73) 0.001
71 (71–72) 73 (72–74) 71 (70–72) 0.001
74 (73–75) 74 (72–75) 73 (70–75) 0.003
70 (69–71) 72 (71–74) 71 (70–73) 0.118
69 (68–70) 69 (69–70) 68 (67–69) 0.001
69 (68–70) 70 (69–71) 68 (67–69) 0.001
70 (69–72) 70 (69–71) 71 (69–73) 0.003
68 (67–69) 68 (66–69) 67 (65–68) 0.001
with 2-year survey cycle treated as a continuous variable, and adjusted for sex, ethnicity, and/or
just to the 2000 Census population by the direct method.
od pressure; other abbreviations as in Table 1.: NHA(>20
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August 14, 2012:599–606 Trends in Hypertension(p  0.001 for all, and men and women) from 1999 to 2010.
he high percentiles (75th to 95th) of mean SBP 130 mm
g showed a notable decreasing trend, especially in women,
hereas lower percentiles did not decrease, reflecting the
mprovement in hypertension control from 1999 to 2010,
hich brought down BP among hypertensive people. The
elatively stable trends in lower percentiles also suggested that
revalence of hypertension had no improvement, and preven-
ion of hypertension had little success.
rends in prevalence of hypertension and pre-hypertension.
espite the downward trends in mean SBP and mean DBP,
ypertension prevalence remained constantly high, affecting
0% of the U.S. adult (20 years of age) population in 1999
o 2010. This stable trend was consistent with other studies
10,15,16). We also found that ethnicity, age group, body
eight status, education level, and marital status were
trongly associated with hypertension prevalence. Increased
ypertension prevalence was observed in non-Hispanic
lacks, the overweight and obese group, those with lower
ducation, and participants not currently married. Flegal et
l. (17–19) showed that obesity prevalence remained stable,
ith a possible slight increase from 1999 to 2010. From
999 to 2010, among participants with complete BP mea-
urements, obesity prevalence increased by 5.5% (p  0.001
or trend) from 30.0% (95% CI: 26.9% to 33.1%) to 35.5%
95% CI: 33.7% to 37.3%), which might partially explain
Figure 1 Select Percentiles for Mean SBP and DBP Among U.S
High percentiles (75th to 95th) of mean systolic blood pressure (SBP) 130 mm
DBP  diastolic blood pressure.he lack of improvement in hypertension prevalence. Factors ether than obesity were also likely to contribute to the
dverse trend in hypertension prevalence, such as increasing
onsumption of dietary sodium, the increasingly sedentary
ifestyle, and the suboptimal levels of health literacy among the
eneral U.S. population (20,21). Therefore, improving diet and
ifestyle (10,22) for the entire population might have some
mpact on improving hypertension prevention (23) and help to
everse the adverse trend in hypertension prevalence.
rends in awareness, management, and control of hyper-
ension. There were significant improvements in aware-
ess, management, and control of hypertension from 1999
o 2010 in almost all gender/ethnicity groups. However,
on-Hispanic black and Mexican-American women did not
how any significant increase in awareness (p 0.182 and p
.076, respectively), and non-Hispanic black men showed no
ignificant increase in control in management (p  0.707).
onetheless, the awareness, management, and control rates
emained poor in 2009 to 2010 (74.7% for awareness, 72.3%
or management, 45.1% for control, and 61.9% for control in
anagement); what is worse, these rates showed no improve-
ent from 2007 to 2010. These subtle improvements can be
scribed to the heavy campaign of programs, guidelines, and
olicies to facilitate hypertension prevention, detection and/or
wareness, treatment, and control by several national initiatives
24–27), although it also reflected the relatively small success
chieved by these initiatives. Additionally, disparities were
lts From 1999 to 2010
wed a notable decreasing trend, especially in women.. Adu
Hg shovident among sex, age groups, and ethnicity. Men, young
to the
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awareness, management, and control rates. For men, the
middle-aged group had a better control rate. However, in
non-Hispanic whites and Mexican Americans, control rates
decreased with age. For participants who managed their
hypertension, Mexican Americans and non-Hispanic blacks
had lower control rates compared with non-Hispanic whites,
and older people had lower control rates than younger and
middle-aged people. Age-related differences in control might
be explained by increased prevalence of treatment-resistant
hypertension in older people (28). Because hypertension is a
major risk factor for cardiovascular events in the elderly,
improving control in this population would be extremely
beneficial (29,30). These findings suggest that public health
efforts should be directed toward increasing awareness, man-
agement, and control among men, Mexican Americans, and
young people, while increasing control and treatment of
hypertension in minority groups and older people. Behavioral
telephone intervention and home BP monitoring were found
to be effective to promote BP control in a clinical trial by
Bosworth et al. (31), and more large randomized trials would
further validate the efficacy of such intervention.
Clinical implications. Our findings had several clinical
implications. First, there was no improvement in hyperten-
Age–Adjusted Prevalence of Hypertension and Pre-Hypertension amTable 3 Age–Adjusted Prevalence of Hypertension and Pre-Hyp
1999–2000 2001–2002 2003–20
Hypertension
All 29.6 (26.7–32.4) 29.0 (27.3–30.8) 30.7 (28.5–3
20–39 yrs 7.6 (4.5–10.7) 6.7 (5.6–7.8) 7.2 (5.6–8.
40–59 yrs 30.2 (26.3–34.1) 29.3 (25.6–33.0) 33.1 (28.7–3
60 yrs 66.1 (62.2–69.9) 66.9 (63.4–70.4) 67.2 (63.9–7
Male 29.1 (24.9–33.2) 27.6 (25.1–30.1) 31.6 (28.5–3
NH white 28.1 (23.3–33.0) 26.4 (24.1–28.7) 30.8 (27.0–3
NH black 38.0 (35.3–40.7) 41.2 (37.9–44.5) 39.8 (35.8–4
Mex Am 27.4 (23.8–30.9) 23.1 (19.7–26.5) 27.1 (23.2–3
Female 29.7 (27.4–32.0) 30.1 (28.4–31.7) 29.7 (27.3–3
NH white 27.4 (24.3–30.6) 28.5 (26.6–30.5) 28.2 (25.5–3
NH black 40.8 (37.6–44.1) 42.6 (37.9–47.3) 41.7 (37.3–4
Mex Am 27.8 (24.2–31.4) 23.7 (21.8–25.6) 29.5 (25.4–3
Pre-hypertension 
hypertension
All 55.8 (52.7–59.0) 54.0 (52.0–56.0) 55.7 (53.2–5
20–39 yrs 33.5 (28.4–38.5) 30.3 (27.7–32.8) 30.2 (27.1–3
40–59 yrs 59.2 (54.1–64.3) 58.4 (54.6–62.2) 63.7 (59.5–6
60 yrs 88.7 (86.4–91.0) 87.6 (85.1–90.1) 86.3 (83.9–8
Male 62.6 (58.0–67.1) 59.1 (55.2–63.0) 61.7 (58.0–6
NH white 61.2 (55.8–66.5) 58.1 (54.3–62.0) 61.7 (57.0–6
NH black 70.2 (65.1–75.3) 72.5 (69.0–75.9) 68.4 (63.0–7
Mex Am 64.2 (58.6–69.7) 56.2 (51.0–61.5) 54.3 (47.0–6
Female 48.9 (46.4–51.4) 48.9 (47.0–50.8) 49.5 (47.4–5
NH white 46.8 (43.4–50.1) 47.1 (44.6–49.6) 47.7 (45.1–5
NH black 59.3 (55.4–63.2) 60.7 (57.8–63.6) 61.2 (57.2–6
Mex Am 48.1 (45.2–51.0) 42.6 (39.4–45.8) 48.6 (44.4–5
Values are % (95% confidence interval). *p value for linear trend, assessed with regression models,
when appropriate. Age-adjusted: use the 20 to 39, 40 to 59, and 60 years age groups to adjust
Abbreviations as in Tables 1 and 2.sion prevalence. To decrease hypertension prevalence, effec-tive population-based strategies should be taken for hyper-
tension prevention through advocating healthful eating and
lifestyle in the entire population. Preventive population-
level interventions tailored to the built environment and the
food environment might lead to health benefits for the
entire population (18). Second, awareness, management,
and control of hypertension remained poor, with no im-
provement from 2007 to 2010. Therefore, strategies should
be initiated to further improve hypertension detection,
treatment, and control, especially in minority groups. Ad-
ditionally, men, Mexican Americans, and 20 to 39 year olds
had lower hypertension awareness, management, and con-
trol rates. Non-Hispanic blacks, Mexican Americans, and
older people were less likely to achieve BP control when
treating hypertension, suggesting that more efforts should
be made to increase hypertension detection, manage-
ment, and control in men, Mexican Americans, and the
younger group, and to increase hypertension control
among minority and elderly patients receiving hyperten-
sion treatment.
Study limitations. Our report had the following limita-
tions: low hypertension prevalence and small sample size in
the younger group (20 to 39 years old) in each 2-year survey
cycle made it impossible to perform trend analysis in any 20-
U.S. Adults (>20 Years): NHANES 1999 to 2010sion among U.S. Adults (>20 Years): NHANES 1999 to 2010
2005–2006 2007–2008 2009–2010 p Value*
29.9 (28.0–31.8) 30.6 (29.2–32.0) 29.5 (27.7–31.4) 0.763
7.3 (5.4–9.1) 8.2 (6.4–9.9) 7.0 (5.5–8.6) 0.862
31.2 (27.6–34.8) 32.2 (29.7–34.7) 30.3 (26.3–34.3) 0.696
66.5 (63.3–69.8) 66.5 (62.9–70.0) 66.7 (63.1–70.2) 0.948
30.7 (28.1–33.4) 31.2 (29.6–32.7) 30.5 (27.9–33.1) 0.218
30.2 (26.9–33.4) 31.4 (29.2–33.5) 29.8 (26.4–33.1) 0.141
42.4 (36.8–48.0) 38.9 (33.5–44.3) 39.6 (37.1–42.2) 0.676
21.1 (17.7–24.5) 27.6 (22.2–33.0) 26.3 (22.5–30.2) 0.882
28.9 (27.2–30.5) 29.9 (28.2–31.6) 28.5 (26.6–30.3) 0.286
27.0 (25.2–28.9) 28.7 (26.1–31.4) 26.9 (24.1–29.7) 0.529
42.4 (39.7–45.1) 43.8 (40.2–47.3) 43.1 (37.8–48.4) 0.382
23.2 (19.7–26.6) 26.0 (23.3–28.7) 27.7 (25.0–30.3) 0.637
54.9 (52.3–57.5) 54.2 (51.7–56.7) 52.6 (50.1–55.0) 0.128
32.4 (28.8–35.9) 31.4 (27.5–35.3) 31.0 (29.2–32.9) 0.707
60.8 (57.1–64.5) 58.4 (54.5–62.3) 56.0 (51.5–60.6) 0.262
83.9 (80.3–87.6) 86.4 (84.5–88.2) 83.8 (80.7–87.0) 0.011
61.7 (58.7–64.7) 60.6 (57.4–63.8) 59.7 (56.8–62.6) 0.557
60.9 (56.9–64.8) 61.4 (57.8–65.1) 59.9 (56.2–63.6) 0.915
73.6 (69.2–78.0) 65.4 (59.8–71.0) 66.1 (61.8–70.4) 0.080
58.1 (53.6–62.6) 60.5 (51.2–69.8) 59.4 (55.4–63.4) 0.930
48.1 (45.3–50.9) 47.8 (45.3–50.2) 45.4 (42.8–48.0) 0.025
47.5 (43.8–51.3) 46.4 (42.9–50.0) 43.5 (40.4–46.5) 0.079
59.8 (55.9–63.7) 59.4 (53.7–65.1) 62.5 (55.7–69.2) 0.625
42.7 (37.5–48.0) 43.8 (35.4–52.3) 43.4 (40.8–46.1) 0.156
ear survey cycle treated as a continuous variable, and adjusted for sex, ethnicity, and/or age group
2000 Census population by the direct method.ongerten
04
2.9)
8)
7.5)
0.5)
4.6)
4.6)
3.9)
1.0)
2.0)
0.9)
6.1)
3.6)
8.1)
3.2)
8.0)
8.8)
5.5)
6.5)
3.8)
1.6)
1.7)
0.3)
5.2)
2.9)
with 2-yto 39-year-old gender/ethnicity subgroups. Hispanics other
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1999–2000 2001–2002 2003–2004 2005–2006 2007–2008 2009–2010 p Value*
Awareness
All 63.8 (57.2–70.4) 63.7 (60.0–67.3) 67.7 (61.8–73.6) 69.2 (64.6–73.8) 74.6 (67.8–81.5) 74.0 (68.6–79.4) 0.001
20–39 yrs 51.4 (36.2–66.5) 50.0 (43.4–56.7) 54.0 (41.1–66.9) 52.4 (42.6–62.3) 65.5 (50.1–80.9) 58.8 (47.4–70.3) 0.165
40–59 yrs 73.1 (67.2–79.1) 72.1 (66.7–77.5) 75.1 (69.7–80.5) 79.2 (74.7–83.7) 79.1 (74.3–83.8) 84.1 (80.4–87.7) 0.001
60 yrs 70.0 (66.3–73.8) 73.4 (70.9–76.0) 79.3 (75.5–83.2) 81.9 (78.6–85.1) 83.2 (80.4–85.9) 84.0 (80.8–87.1) 0.001
Male 63.3 (57.6–69.0) 56.8 (53.5–60.0) 68.2 (62.3–74.0) 64.2 (59.4–68.9) 68.6 (60.5–76.6) 69.7 (62.0–77.4) 0.001
NH white 66.0 (60.6–71.3) 57.1 (49.9–64.4) 69.9 (61.5–78.3) 63.3 (56.2–70.4) 72.2 (62.0–82.5) 68.9 (57.3–80.4) 0.001
NH black 59.4 (44.3–74.6) 67.5 (58.4–76.7) 59.8 (46.2–73.3) 65.3 (57.6–73.1) 61.7 (51.4–72.0) 82.7 (73.4–92.0) 0.002
Mex Am 45.9 (35.1–56.7) 34.0 (27.9–40.0) 67.3 (52.3–82.3) 58.0 (44.5–71.5) 58.1 (52.9–63.3) 62.0 (48.7–75.3) 0.003
Female 61.0 (50.7–71.4) 74.9 (68.4–81.4) 68.6 (58.2–79.1) 84.5 (76.2–92.7) 83.4 (78.2–88.6) 80.7 (74.5–86.8) 0.001
NH white 59.9 (47.4–72.4) 75.0 (62.4–87.7) 68.2 (52.4–83.9) 91.4 (88.3–94.5) 83.8 (76.6–91.1) 80.2 (71.9–88.4) 0.001
NH black 75.2 (61.7–88.7) 84.6 (78.7–90.5) 73.0 (59.7–86.4) 84.6 (71.7–97.6) 86.4 (79.2–93.6) 81.5 (69.2–93.8) 0.182
Mex Am 61.1 (39.7–82.4) 58.0 (46.1–69.9) 51.5 (37.8–65.2) 73.7 (50.2–97.2) 66.3 (55.3–77.3) 67.0 (51.5–82.5) 0.076
Management
All 56.9 (51.3–62.6) 56.2 (53.9–58.5) 59.8 (53.5–66.2) 61.2 (57.5–64.9) 66.9 (62.6–71.2) 71.6 (65.7–77.5) 0.001
20–39 yrs 37.6 (26.7–48.4) 40.6 (36.0–45.3) 41.4 (26.4–56.4) 38.8 (29.1–48.4) 51.7 (41.8–61.7) 54.7 (43.0–66.4) 0.014
40–59 yrs 70.5 (65.5–75.5) 62.7 (58.0–67.3) 68.2 (61.7–74.8) 73.2 (69.5–76.9) 73.0 (67.7–78.3) 81.1 (76.8–85.3) 0.001
60 yrs 68.3 (62.6–74.1) 72.4 (68.6–76.2) 77.9 (75.0–80.7) 80.3 (77.3–83.3) 83.0 (80.0–86.1) 85.3 (82.6–88.0) 0.001
Male 53.5 (47.0–59.9) 49.7 (46.9–52.5) 58.4 (52.1–64.7) 56.2 (51.6–60.9) 60.0 (54.2–65.8) 65.5 (57.5–73.5) 0.001
NH white 57.1 (50.2–64.0) 49.8 (43.8–55.8) 59.9 (51.1–68.8) 55.8 (49.1–62.6) 62.4 (54.9–70.0) 64.7 (53.0–76.4) 0.001
NH black 46.8 (36.4–57.2) 53.4 (46.6–60.2) 53.7 (41.4–66.0) 60.4 (52.5–68.3) 59.6 (48.2–71.0) 72.6 (61.6–83.5) 0.001
Mex Am 40.7 (26.7–54.7) 25.9 (22.4–29.3) 51.6 (36.8–66.5) 48.2 (35.2–61.1) 54.5 (46.1–62.8) 55.6 (40.1–71.1) 0.006
Female 61.6 (56.0–67.2) 66.4 (60.2–72.6) 64.1 (54.2–74.1) 78.8 (71.6–85.9) 76.6 (71.7–81.5) 81.0 (74.2–87.9) 0.001
NH white 64.5 (57.9–71.2) 65.0 (50.9–79.1) 64.4 (49.9–78.9) 88.2 (85.3–91.0) 75.8 (66.5–85.1) 80.4 (71.7–89.1) 0.001
NH black 65.6 (52.7–78.6) 72.6 (64.5–80.7) 65.4 (53.8–77.1) 77.8 (67.1–88.5) 79.3 (74.0–84.7) 85.8 (73.8–97.7) 0.002
Mex Am 52.6 (31.5–73.7) 48.1 (35.2–61.0) 51.6 (41.5–61.6) 66.8 (42.5–91.2) 64.2 (54.2–74.2) 66.6 (53.0–80.2) 0.001
Control
All 27.5 (22.6–32.4) 33.6 (29.8–37.3) 36.6 (29.3–43.9) 37.6 (33.5–41.7) 46.1 (40.4–51.9) 46.5 (41.1–51.9) 0.001
20–39 yrs 14.7 (8.8–20.7) 30.0 (22.3–37.6) 30.3 (15.3–45.3) 24.5 (15.9–33.1) 41.2 (29.5–53.0) 33.0 (23.0–43.0) 0.003
40–59 yrs 41.2 (34.6–47.7) 37.1 (31.9–42.2) 41.1 (33.6–48.5) 47.4 (42.6–52.1) 49.9 (45.1–54.7) 55.7 (51.0–60.5) 0.001
60 yrs 27.4 (22.7–32.0) 34.1 (31.3–37.0) 40.4 (36.5–44.2) 44.6 (40.1–49.1) 48.4 (44.4–52.5) 54.9 (50.9–58.9) 0.001
Male 28.3 (22.0–34.7) 28.2 (24.0–32.4) 37.1 (29.6–44.5) 34.3 (29.8–38.8) 40.9 (34.8–47.0) 40.3 (33.7–46.9) 0.001
NH white 32.3 (26.1–38.4) 29.9 (24.0–35.8) 39.3 (28.9–49.8) 35.0 (27.8–42.3) 45.0 (38.5–51.5) 42.8 (35.6–50.1) 0.001
NH black 22.7 (14.0–31.4) 28.1 (23.2–33.1) 29.8 (21.9–37.7) 32.4 (24.9–40.0) 31.5 (22.0–41.0) 36.2 (24.8–47.6) 0.009
Mex Am 11.3 (8.6–14.0) 9.9 (5.4–14.5) 31.7 (21.2–42.2) 29.1 (19.6–38.6) 37.2 (30.8–43.6) 22.7 (15.5–29.9) 0.001
Female 27.6 (20.9–34.3) 43.9 (36.9–50.8) 38.7 (27.8–49.6) 52.1 (41.9–62.2) 54.0 (46.1–61.9) 56.3 (49.2–63.3) 0.001
NH white 29.3 (19.7–38.9) 47.1 (32.9–61.4) 41.5 (25.4–57.6) 70.4 (68.6–72.2) 58.5 (48.7–68.4) 60.1 (50.1–70.1) 0.001
NH black 23.2 (16.4–30.0) 37.9 (29.8–45.9) 33.0 (25.6–40.4) 44.9 (34.5–55.3) 47.6 (38.4–56.9) 49.8 (40.2–59.4) 0.001
Mex Am 31.4 (10.7–52.1) 31.0 (16.2–45.8) 26.9 (15.3–38.6) 30.8 (11.1–50.4) 36.9 (16.2–57.6) 38.4 (19.4–57.3) 0.001
Control in management
All 46.5 (38.6–54.5) 62.1 (55.5–68.8) 63.4 (56.0–70.8) 62.0 (55.5–68.4) 70.5 (64.9–76.1) 64.4 (59.9–68.9) 0.001
20–39 yrs 39.2 (23.4–55.1) 73.8 (57.4–90.1) 73.1 (58.3–87.9) 63.2 (48.2–78.1) 79.7 (67.2–92.1) 60.4 (50.2–70.6) 0.087
40–59 yrs 58.4 (50.6–66.1) 59.1 (54.0–64.3) 60.2 (53.4–66.9) 64.7 (58.3–71.1) 68.4 (64.4–72.4) 68.8 (64.1–73.4) 0.001
60 yrs 40.0 (34.5–45.6) 47.1 (44.3–49.9) 51.9 (46.9–56.8) 55.5 (51.2–59.9) 58.3 (54.2–62.5) 64.4 (61.1–67.6) 0.001
Male 50.7 (39.7–61.7) 57.7 (47.2–68.2) 65.4 (57.5–73.2) 60.4 (50.7–70.2) 69.8 (63.6–76.0) 59.9 (52.9–66.8) 0.001
NH white 54.0 (41.2–66.7) 60.9 (48.3–73.5) 67.1 (55.0–79.1) 62.9 (48.2–77.5) 74.1 (68.1–80.0) 65.0 (57.2–72.8) 0.006
NH black 46.2 (22.5–69.9) 55.2 (42.0–68.4) 55.9 (40.6–71.3) 53.7 (42.9–64.5) 51.5 (35.5–67.5) 49.7 (30.0–69.4) 0.707
Mex Am 22.2 (17.0–27.4) 49.2 (24.0–74.4) 57.7 (48.8–66.7) 55.0 (28.4–81.5) 69.4 (55.7–83.2) 38.5 (24.9–52.1) 0.045
Female 43.4 (29.8–57.1) 67.4 (61.1–73.7) 61.8 (52.3–71.3) 66.1 (56.9–75.4) 71.2 (64.0–78.4) 69.4 (63.6–75.3) 0.001
NH white 41.3 (19.5–63.1) 74.4 (71.4–77.3) 65.7 (54.1–77.2) 77.8 (74.9–80.7) 78.7 (76.6–80.8) 74.8 (66.1–83.5) 0.001
NH black 33.9 (20.8–47.0) 53.1 (41.3–64.9) 48.2 (32.9–63.6) 57.9 (44.7–71.0) 60.3 (49.6–71.0) 57.9 (52.0–63.8) 0.001
Mex Am 62.2 (52.7–71.7) 72.3 (63.3–81.3) 66.1 (59.2–73.0) 47.6 (26.5–68.8) 56.6 (26.1–87.0) 59.7 (32.8–86.5) 0.031
Values are % (95% confidence interval). *p value for linear trend, assessed with regression models, with 2-year survey cycle treated as a continuous variable, and adjusted for sex, ethnicity, and/or age group
when appropriate. Age-adjusted: use the 20 to 39, 40 to 59, and 60 years age groups to adjust to the 2000 Census population by the direct method.
Abbreviations as in Tables 1 and 2.
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2006, and any analysis on Hispanic groups before 2007 to
2008 was unreliable; thus, we only reported trends in
Mexican Americans.
Conclusions
In 2009 to 2010, the prevalence of hypertension was 30.5%
among men and 28.5% among women. From 1999 to 2010,
hypertension prevalence remained constantly high; hyper-
tension awareness, management, and control were signifi-
cantly improved, but remained poor, and did not improve
from 2007 to 2010. Strategies should be taken to improve
hypertension prevention in the whole population, to in-
crease hypertension detection, management, and control
among men, Mexican Americans, and young people, and to
increase control of hypertension among older people and
minority groups receiving hypertension treatment.
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